Resistant hypertension and renal denervation where to now?

Cardiovascular Therapeutics

Volumn 33, Issue 1, 2015, Pages 9-14

  Shaw, James A ^a,b   Warren, Josephine L ^c  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Hypertension; Interventional cardiology; Lipids disorder atherosclerosis; Renal dysfunction

Indexed keywords

ADRENERGIC SYSTEM; ANATOMY; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL STUDY; DIASTOLIC BLOOD PRESSURE; ELEVATED BLOOD PRESSURE; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY DENERVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; SYMPATHETIC FUNCTION; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CATHETER ABLATION; CLINICAL TRIAL (TOPIC); DENERVATION; HYPERTENSION; INNERVATION; KIDNEY; PROCEDURES;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CATHETER ABLATION; CLINICAL TRIALS AS TOPIC; DENERVATION; HUMANS; HYPERTENSION; KIDNEY;

EID: 84921449074     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12103     Document Type: Review

References (33)

1. Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1, 266 cases. J Am Med Assoc 1953;152:1501-1504.
2. Hoobler SW, Manning JT, Paine WG, et al. The effects of splanchnicectomy on the blood pressure in hypertension; a controlled study. Circulation 1951;4:173-183.
3. Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA 2014;311:2216-2224.
4. Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens 2014. [Epub ahead of print].
5. Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, Toennes SW. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 2013;31:766-774.
6. Daugherty SL, Powers JD, Magid DJ, et al. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension 2012;60:303-309.
7. Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlof B, Poulter NR. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens 2011;29:2004-2013.
8. Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Aban I, Oparil S, Calhoun DA. Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension 2008;51:339-344.
9. Pimenta E, Gaddam KK, Oparil S. Mechanisms and treatment of resistant hypertension. J Clin Hypertens (Greenwich) 2008;10:239-244.
10. Esler M. Renal denervation for treatment of drug-resistant hypertension. Trends Cardiovasc Med 2014. [Epub ahead of print].
11. Esler M, Jennings G, Korner P, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988;11:3-20.
12. Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet 1953;1:403-408.
13. Dart AM, Kingwell BA. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975-984.
14. Muntner P, Davis BR, Cushman WC, et al. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Hypertension 2014;64:1012-1021.
15. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-621.
16. Esler M, Dudley F, Jennings G, et al. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 1992;116:446-455.
17. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-1918.
18. DiBona GF. Role of the renal nerves in hypertension. Semin Nephrol 1991;11:503-511.
19. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275-1281.
20. Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014;383:622-629.
21. Okon T, Heinemann D, Kulle K, et al. Simplicity Flex: A randomized sham controlled trial of renal denervation in mild resistant hypertension. Presented at Transcatheter Therapeutics: Washington. 2014.
22. Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 2013;34:2132-2140.
23. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-1909.
24. Gould BA, Mann S, Davies AB, Altman DG, Raftery EB. Does placebo lower blood-pressure? Lancet 1981;2:1377-1381.
25. Esler MD, Bohm M, Sievert H, et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J 2014;35:1752-1759.
26. Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol 2012;35:528-535.
27. Bhatt DL. What does the future hold for renal denervation? Eur Heart J 2014;35:1695-1696.
28. Bakris GL, Townsend RR, Liu M, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol 2014;64:1071-1078.
29. Messerli FH, Bangalore S. Renal denervation for resistant hypertension? N Engl J Med 2014;370:1454-1457.
30. Bhatt DL, Bakris GL. Renal denervation for resistant hypertension. N Engl J Med 2014;371:184.
31. Kandzari DE, Bhatt DL, Brar S, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 2014. [Epub ahead of print].
32. Sakakura K, Ladich E, Cheng Q, et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 2014;64:635-643.
33. Tzafriri AR, Mahfoud F, Keating JH, et al. Innervation patterns may limit response to endovascular renal denervation. J Am Coll Cardiol 2014;64:1079-1087.